Intercontinental Wealth Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Intercontinental Wealth Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 08, 2019	SELL	$91.83 - $120.68 $30,854 - $40,548	-336 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$85.79 - $126.46 $28,825 - $42,490	336 New	336 $34,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.